Concepedia

Radhika Nallangi

RN

8

Publications

187

Citations

8

H-Index

2013

Active since

Affiliations

Birla Institute of Technology and Science, Pilani(Current)

Birla Institute of Technology and Science - Hyderabad Campus

Radhika Nallangi is an author at Birla Institute of Technology and Science, Pilani specializing in pharmacology, drug discovery, and drug resistance.

Top concepts

Publications per year

2013–2020

8

Publications

8

Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors

Ganesh Samala, Parthiban Brindha Devi, Radhika Nallangi et al. · European Journal of Medicinal Chemistry · 2013 · 34 citations · Full text

, , +5

Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads

Ganesh Samala, Parthiban Brindha Devi, Radhika Nallangi et al. · Bioorganic & Medicinal Chemistry · 2014 · 33 citations · Full text

, , +7

Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors

Ganesh Samala, Radhika Nallangi, Parthiban Brindha Devi et al. · Bioorganic & Medicinal Chemistry · 2014 · 31 citations · Full text

, , +8

Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors

Prasanthi Malapati, Vagolu Siva Krishna, Radhika Nallangi et al. · European Journal of Medicinal Chemistry · 2017 · 31 citations

, , +8

Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors

Vagolu Siva Krishna, Shan Zheng, Estharla Madhu Rekha et al. · European Journal of Medicinal Chemistry · 2020 · 23 citations

, , +9

Rows per page

1–5 of 8